Overall Technical outlook

Price Summary

On 2025-08-14, Gland Pharma Limited's stock opened at 1948.0, reached a high of 1998.0, dropped to a low of 1945.0, and closed up 1.43% at 1975.8, with a trading volume of 208200 shares.
Over the previous 52 weeks, the stock reached a high of 2102.1 and a low of 1392.8.
The projected price range for Gland Pharma Limited is between 1138.0 and 2340.0, with an expected mean price of 1865.6666, according to 12 analysts.

Technicals

Support and Resistance: The current price of 1975.8 is supported at 1888.3, with resistance at 2000.3. This suggests that the price for GLAND might remain between these levels, where 1888.3 acts as a floor and 2000.3 as a ceiling in the market.
GLAND supportResistance 4766c3
Support/Resistance for GLAND


Aroon: The current reading of the AROON is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
GLAND aroon 4766c3
Aroon chart for Gland Pharma Limited


Bol. Bands: The BOLL BANDS is showing a neutral stance, not indicating a clear upward or downward trend for Gland Pharma Limited. This suggests a period of market balance, where neither side is showing dominance.
GLAND bbands 4766c3
Bolinger Bands chart for Gland Pharma Limited


Parabolic SAR: The PSAR for GLAND remains bearish, establishing a key resistance level that could hinder upward movement. This ongoing bearish outlook suggests that the market may face challenges in breaking higher, with the resistance level acting as a barrier to potential gains.
GLAND psar 4766c3
Parabolic Stop and Reverse chart for Gland Pharma Limited


Stochastic: The current reading of the STOCHASTIC indicator suggests a neutral stance, with no clear signals indicating an upward or downward direction. This lack of directional bias suggests the market may be in a period of consolidation or uncertainty.
GLAND stoch 4766c3
Stochastic chart for Gland Pharma Limited


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
GLAND trippleSMA 4766c3
Tripple SMA chart for Gland Pharma Limited


When assessing a company's technical performance, such as stock price fluctuations and trading volume, it is crucial to first examine its fundamentals. These fundamentals include financial health, profitability, and growth potential. Additionally, understanding the industry's dynamics, including competitive pressures and market trends, is key to contextualizing the company's performance. By integrating these factors, a more comprehensive and meaningful analysis can be conducted, leading to more informed investment decisions.